Ama-algorithms e-FDA-clearred Artificial Intelligence (AI) athola izinkomba eziphambili zesifo senhliziyo manje ayatholakala kubasebenzi bezempilo kuhlelo lokusebenza olusha lwe-Eko.
I-Eko, inkampani yezempilo yedijithali ethuthukisa ukutholwa kwezifo zenhliziyo namaphaphu, namuhla imemezele ukwethulwa kwe-Eko App yayo esanda kuklanywa kabusha, ezoguqula ukusebenzisana kweziguli kube yithuba lokuhlola isifo senhliziyo nemithambo yegazi. Isifo senhliziyo siyimbangela ehamba phambili yokufa e-US, futhi akukaze kube nesixazululo esisebenzayo nesingabizi sokuhlola isifo senhliziyo ekuhlolweni komzimba kuze kube manje.
"Imisebenzi yamanje yomtholampilo yokuthola isifo senhliziyo ngokuvamile ihlanganisa ukuhlolwa okubizayo okwenziwa uchwepheshe esimweni esiphuthumayo, okwenza ukuxilongwa kusenesikhathi kucishe kungenzeki," kusho uDkt. Adam Saltman, Isikhulu Esiphezulu Sezokwelapha, u-Eko. “Ukuhlolwa komzimba kunikeza ithuba lokusheshe kutholwe isifo senhliziyo. Kodwa-ke, imisindo engaba ngu-80% yenhliziyo engavamile ayibonwa lapho ukuhlolwa kwenziwa nge-stethoscope yendabuko. Lokhu kungabambezela imishanguzo esindisa impilo yeziguli.”
U-Eko uguqule i-stethoscope yendabuko yaba ithuluzi lokuthola izifo elihlakaniphile ukusiza odokotela babone isifo senhliziyo kalula ngesikhathi sokuhlolwa komzimba. Ulayini wabo wama-stethoscopes ahlakaniphile, uma ubhangqwe nesofthiwe yawo ezenzakalelayo yokuhlonza izifo kusetshenziswa i-Eko App, ihlaziya imisindo yenhliziyo ngama-algorithms e-AI asulwe yi-FDA futhi afakazelwe ngokomtholampilo.* Ngemizuzwana, ama-algorithms angathola ukububula kwenhliziyo kanye ne-atrial fibrillation (AFib)* * ngokusebenza okufanayo kochwepheshe babantu.
"Ochwepheshe bezempilo be-Frontline bayindlela yethu engcono kakhulu yokuzivikela ekubambeni isifo senhliziyo kusenesikhathi, kodwa banenselele yokwenza kanjalo ngamathuluzi aphelelwe yisikhathi, isikhathi esanele, nezinsiza ezinganele," kusho uConnor Landgraf, i-CEO kanye nomsunguli-Co-founder, u-Eko. “Ngenxa yesifo esigcwele umphakathi wethu, kubalulekile ukuthi sinikeze bonke ochwepheshe bezempilo isisombululo esibasiza ukuthi baxilonge ngokuzethemba okwengeziwe futhi banikeze iziguli zabo ukunakekelwa okungcono kakhulu. Ngale ndlela sizosindisa izigidi zabantu eminyakeni ezayo.”
I-algorithm ye-Eko's AI yokukhomba ukububula kwenhliziyo, inkomba ehamba phambili yesifo se-valve yenhliziyo, yaqinisekiswa ngokomtholampilo ukuthi yenza ngokuzwela okungama-87.6% kanye nokucaciswa okungu-87.8%. I-algorithm yabo yokuthola i-fibrillation ye-atrial eyenziwa ngokuzwela kwe-98.9% kanye nokucaciswa okungu-96.9%. Ukuqinisekiswa komhlaba wangempela kwe-algorithm yokuthola ukububula kwenhliziyo ka-Eko kuvele ekushicilelweni kwakamuva, okubuyekezwe ontanga ku-Journal of the American Heart Association. Kwakuyisifundo esikhulu kunazo zonke ekuhlaziyweni kwe-AI kokububula kwenhliziyo kuze kube manje.
“Ubuchwepheshe be-Eko bunginike isiqiniseko esengeziwe sokuthola nokuqinisekisa ukuvungama kwenhliziyo kanye nokushaya kwenhliziyo ezigulini zami,” kusho uJoanna Kmiecik, MD, Uchwepheshe Wezokwelapha Zomndeni. “Ukusebenziseka kalula nokuphatheka kwemvelo yemikhiqizo ka-Eko ingisiza ukuthi ngihlole iziguli khona ehhovisi lami, kube nomthelela omncane endleleni yami yokuhlola umzimba. Uma ngizwa inhliziyo izwakala isola isifo, u-Eko uqinisekisa ngokunembile ngemizuzwana. Lokhu kungisiza ukuba nginqume izinqumo zokunakekela futhi ngibhekise kuchwepheshe ngokuzethemba lapho kufaneleka. Iziguli zami zijabulela ngisho nokuthi zingasebenzisa kanjani uhlelo lokusebenza, futhi ngizizwa ngiwudokotela ongcono.”
LOKHO ONGAKUTHATHE KULESI SIHLOKO:
- “With a disease that is so pervasive in our society, it is imperative that we provide every healthcare professional with a solution that helps them diagnose with more confidence and give their patients the best care possible.
- Eko’s AI algorithm to identify heart murmurs, a leading indicator of heart valve disease, was clinically validated to perform at a sensitivity of 87.
- Eko, a digital health company advancing heart and lung disease detection, today announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease.
